As of 2024-12-13, the Relative Valuation of Hikma Pharmaceuticals PLC (HIK.L) is 2,263.36 GBP. This relative valuation is based on P/E multiples. With the latest stock price at 1,964.00 GBP, the upside of Hikma Pharmaceuticals PLC based on Relative Valuation is 15.2%.
The range of the Relative Valuation is 1,942.49 - 2,597.05 GBP.
| Range | Selected | |
| Trailing P/E multiples | 19.4x - 23.7x | 20.8x |
| Forward P/E multiples | 24.0x - 28.0x | 26.2x |
| Fair Price | 1,942.49 - 2,597.05 | 2,263.36 |
| Upside | -1.1% - 32.2% | 15.2% |
| Date | P/E |
| 2024-12-10 | 15.25 |
| 2024-12-09 | 15.32 |
| 2024-12-06 | 15.10 |
| 2024-12-05 | 15.17 |
| 2024-12-04 | 15.29 |
| 2024-12-03 | 15.35 |
| 2024-12-02 | 15.13 |
| 2024-11-29 | 15.05 |
| 2024-11-28 | 15.14 |
| 2024-11-27 | 15.31 |
| 2024-11-26 | 15.37 |
| 2024-11-25 | 15.49 |
| 2024-11-22 | 15.25 |
| 2024-11-21 | 14.64 |
| 2024-11-20 | 14.43 |
| 2024-11-19 | 14.38 |
| 2024-11-18 | 14.23 |
| 2024-11-15 | 14.20 |
| 2024-11-14 | 14.03 |
| 2024-11-13 | 14.15 |
| 2024-11-12 | 14.28 |
| 2024-11-11 | 14.37 |
| 2024-11-08 | 14.32 |
| 2024-11-07 | 14.09 |
| 2024-11-06 | 13.86 |
| 2024-11-05 | 14.24 |
| 2024-11-04 | 14.52 |
| 2024-11-01 | 14.65 |
| 2024-10-31 | 14.51 |
| 2024-10-30 | 14.88 |
| 2024-10-29 | 15.02 |
| 2024-10-28 | 15.12 |
| 2024-10-25 | 15.19 |
| 2024-10-24 | 15.24 |
| 2024-10-23 | 15.43 |
| 2024-10-22 | 15.66 |
| 2024-10-21 | 15.62 |
| 2024-10-18 | 15.63 |
| 2024-10-17 | 15.78 |
| 2024-10-16 | 15.66 |
| 2024-10-15 | 15.34 |
| 2024-10-14 | 15.05 |
| 2024-10-11 | 14.85 |
| 2024-10-10 | 14.82 |
| 2024-10-09 | 14.91 |
| 2024-10-08 | 14.86 |
| 2024-10-07 | 14.70 |
| 2024-10-04 | 14.89 |
| 2024-10-03 | 14.90 |
| 2024-10-02 | 14.96 |